Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,483 total articles
CorMedix (CRMD) looks set for choppy action in the coming weeks, but the shares trade at a valuation that materially understates current revenue power and free cash flow. We recommend a long trade for investors willing to tolerate short-term downside: entry $8.45, stop $6.00, target $20.00, horizon long term (180 trading days).
Energy Services of America (ESOA) is upgraded to a tactical long. The company's $280.7M backlog, exposure to gas distribution and industrial electrification work, and a tight public float set up upside as revenue and profitability recover. Valuation is reasonable on an EV/Sales basis, while short interest and low liquidity mean upside can come quic…
Mosaic (MOS) looks attractive after a recent pullback. The stock trades at roughly $23.50 with a market cap near $7.5B, a low price-to-book (~0.61) and EV/EBITDA of ~6.8x. Near-term headwinds have compressed earnings, but structural upside from supply disruptions, tighter phosphate markets, and new asset optionality justify a long-term trade. Entry…
Voyager Technologies is trading with strong momentum after a string of sector- and company-level catalysts. The stock looks actionable as a tactical long while Starlab manufacturing, defense budget tailwinds, and sector backlog growth give tangible mid-term upside. Execution and cash-burn risks keep this a medium-risk trade.
IBM is no longer the sleepy dividend stalwart of old. With watsonx gaining traction, Red Hat/OpenShift contributing meaningful ARR, and a $1 billion federal quantum award that de-risks infrastructure investment, IBM's AI and hybrid-cloud mix is a catalyst for earnings and multiple expansion. I raise my target to $295 and lay out a trade with entry …
Lumentum (LITE) is benefiting from the AI infrastructure squeeze. Surging demand is translating into sizable customer purchase commitments that make near-term revenue visibility cleaner while creating working-capital and cash-flow pressure. I upgrade LITE to Buy on a tactical long-term trade: entry $880.00, target $1085.68, stop $760.00. Time horiz…
Ituran's Q1 headlines - a $0.50 quarterly dividend, $108M cash and no bank debt - alongside solid free cash flow and improving trading momentum give the stock a tactical long setup. Valuation is reasonable for a cash-generative telematics business, but near-term momentum and an elevated RSI mean entries should be disciplined.
Darling Ingredients (DAR) is showing signs of operational recovery after a difficult stretch in renewable fuels. Fundamentals and cash flow remain intact, valuation is reasonable relative to enterprise cash generation, and technicals show a base near the 50-day average. This is a swing trade: enter around $59.00, target the $66.00 52-week high, and…
IonQ's recent technical milestones and a wave of government funding have reignited investor interest. The company's trapped-ion fidelity claim, a potential SkyWater deal for vertical integration cited in coverage, and improving technical indicators support a tactical long. This trade idea outlines a clear entry at $63.60, a stop at $54.00, and a ta…
Baidu is trading at $131 with a $48B market cap and a stretched valuation gap versus its visible AI momentum. Recent partnership wins, a prospective AI chip IPO, and improving technical support argue for a tactical long. This trade lays out entry, stop, targets, time horizon and the key risks that could derail the setup.
Natural Gas Services Group (NGS) is trading at $41.73 with a market cap near $526M and an enterprise value of roughly $763M. With EV/EBITDA about 9.4, P/B ~1.92 and a newly expanded $300M credit facility to fund fleet growth, NGS looks positioned for a re-rating as rental utilization and pricing stabilize. This trade targets a re-rating to a higher…
American Battery Technology (ABAT) appears to have achieved its first positive gross margin, an operational inflection that changes the narrative from pure dilutive funding to early commercial progress. The stock still trades as a small-cap industrial with stretched valuation metrics and ongoing cash burn, so this idea is a tactical long with a cle…
Carlsberg looks like a sensible long trade over the next 45 trading days. The company’s premiumization, disciplined pricing, and cost control should offset headwinds from commodities and FX. Enter at $90.00, stop at $80.00, target $105.00; horizon: mid term (45 trading days).
Bristol-Myers Squibb is quietly positioning for a fresh growth cycle by pairing AI-driven discovery with near-term oncology and neuroscience catalysts. The stock trades at a reasonable multiple, generates robust free cash flow and pays a >4% dividend, making a measured long with defined risk controls attractive for patient, tactical investors.
Norwegian Cruise Line plunged after a guidance cut and now trades on depressed multiples despite solid demand indicators, an improving technical setup, and an industry with high operating leverage. This is a tactical long trade sized for a bounce and structural recovery — but only with clear stops; balance high operational risk against attractive E…
XIACF is trading below key moving averages on weak momentum but shows signs of overselling while short activity remains elevated. For patient, disciplined traders, a defined long with a conservative stop and a multi-month horizon offers an asymmetric risk-reward: a low-cost bet that the market will eventually price in Xiaomi's hardware-plus-softwar…
NVIDIA sits at the center of the AI boom with a market cap north of $5 trillion and FCF of $119 billion. That dominance is real, but the stock’s multiples (P/S ~20.5, P/E ~32.6) and recent technical deterioration make the current narrative - that every chip order is durable backlog - worth questioning. This trade idea lays out a tactical short with…
Manulife (MFC) looks mispriced after a post-Q1 pullback. The stock trades at a $64.7B market cap, a 3.39% yield and a PE of 15.3. Recent dividend actions and steady fundamentals argue the market punished the wrong quarter. We'll lay out an entry at $38.60, a $42.00 target and a $36.00 stop for a mid-term (45 trading days) swing trade.
Zillow trades near its 52-week low while free cash flow and the growing PropTech rental market argue for a durable re-rating. Legal and regulatory noise has pushed shares down, creating a risk-reward set-up. We surface an actionable long with an entry at $36.85, a $55.00 target, and a $31.00 stop for a long-term play (180 trading days).
Science Applications International (SAIC) trades at a low-teens P/E and generates strong free cash flow, yet recent procurement delays and weaker award outcomes mean revenue growth is uncertain. We favor a cautious long: enter at the current price, cap position size, use a clear stop, and target a re-rating toward prior multiple and contract recove…
LexinFintech (LX) looks cheap on headline metrics and is showing improving profitability and product momentum. Management’s $50M repurchase and a planned $10M CEO purchase, plus consecutive quarterly profit improvements and AI-driven product wins, create a constructive setup. This is a tactical long with a clear entry, stop and target, but the trad…
Diamondback (FANG) looks expensive for the profile: market cap roughly $54B, negative free cash flow, thin cash buffer, and a stretched P/E near 200 despite modest returns on capital. The Iran-related oil rally has pumped the sector, but that same rally is encouraging rotation into integrated majors and fee-based midstream names while exposing sing…
BYD's combination of scale across passenger and commercial EVs, a $113.3B market cap, improving export guidance and an attractive risk/reward near $11.58 make it a pragmatic long. This trade plan sets an entry at $11.58, a $16.50 target and a $10.50 stop for a long-term (180 trading days) position while explaining catalysts, valuation logic and maj…
Nvidia's fundamentals and cash generation are massive, earnings power is resilient, and recent industry signals (memory shortages, surging HBM demand, and Jensen Huang's capital commitments) point to upside that the consensus hasn't fully baked in. This trade idea lays out an actionable long with entry, stops, targets, catalysts and risks for a 180…
Compass Pathways (CMPS) is a volatile, binary biotech with clear upside if regulatory momentum continues. With a market cap of ~$1.65B, roughly $3.03 in reported cash per share and bullish technicals, I recommend a mid-term long trade ahead of an upcoming FDA verdict. Entry, stop and target are provided with rationale and risk controls.
